Effects of a community-based intervention bundle on household transmission of extended spectrum β-lactamase-producing Escherichia coli in rural Burkina Faso to target community-level drivers of antimicrobial resistance in sub-Saharan Africa: a cluster-randomised trial
The Lancet Microbe · 2026
DOI: 10.1016/j.lanmic.2026.101427 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Lancet Microbe, 2026. Verfasst von Raneem Aizouk und 16 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: beta-Lactamases, Escherichia coli, Escherichia coli Infections. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Styrelsen för Internationellt Utvecklingssamarbete, UK Research and Innovation, Joint Programming Initiative on Antimicrobial Resistance.
Abstract (Originalsprache)
BACKGROUND: In sub-Saharan Africa, invasive antimicrobial-resistant infections often originate from community-level acquisition. In this study, we aimed to evaluate the effect of a cluster-level intervention on individual-level extended spectrum β-lactamase-producing Escherichia coli (ESBL-E) acquisition. We assessed whether a behavioural intervention bundle targeting suboptimal antibiotic use and hygiene practices reduced household-level acquisition of ESBL-E. METHODS: We conducted a cluster-randomised controlled trial in 22 village clusters in Nanoro district, Burkina Faso. We enrolled 12 randomly selected households per cluster to assess the intervention effect on ESBL-E household transmission. The intervention comprised three rounds delivered at 3-month intervals and combined WHO Access, Watch, Reserve-based educational and feedback sessions for formal and informal medicine providers with community health education campaigns. Consenting household members provided stool samples before, during, and after intervention rollout, alongside a pre-post household water, sanitation, and hygiene (WASH) survey. ESBL-E acquisition was defined as a transition from a negative to a positive stool sample between consecutive sampling visits, with transition hazards estimated using continuous-time Markov models. We estimated intervention effects on ESBL-E acquisition using Bayesian Markov models. Cox frailty models assessed associations between WASH exposures and acquisition. The study is registered with ClinicalTrials.gov (NCT05378880). FINDINGS: 1203 individuals were enrolled between Oct 11, 2022, and Feb 19, 2024. At baseline, 346 (57%) of 604 individuals in the control household group and 291 (49%) of 599 individuals in the intervention household group tested positive for ESBL-E colonisation. Pre-intervention acquisition incidence rates were 3·8 per 100 person-days (95% credible interval [CrI] 2·0-9·9) in the intervention group and 3·5 per 100 person-days (95% CrI 1·8-9·6) in the control group. The intervention did not change the risk of ESBL-E acquisition in months 1-6 (hazard ratio [HR] 1·02 [95% CrI 0·78-1·31]) but was associated with a reduction in months 6-9 (HR 0·82 [95% CrI 0·56-1·14], probability of a reduction p[HR
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre of Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
- Institut de Recherche en Sciences de la Santé, Direction Régionale du Centre-Ouest/Clinical Research Unit of Nanoro, Nanoro, Burkina Faso.
- Institute of Tropical Medicine, Antwerp, Belgium.
- Centre for Population, Family and Health, University of Antwerp, Antwerp, Belgium.
- Anthropology and Ecology of Disease Emergence Unit, Institut Pasteur, Université Paris Cité, Paris, France.
- Julius Centre for Health Sciences and Primary Care, UMCU, Utrecht University, Netherlands.
Förderung
- Styrelsen för Internationellt Utvecklingssamarbete
- UK Research and Innovation
- Joint Programming Initiative on Antimicrobial Resistance
- Agence Nationale de la Recherche
- Belgisch Ontwikkelingsagentschap
- Fonds Wetenschappelijk Onderzoek
- Wellcome Trust
Zitieren
APA
Aizouk, R., Sibidou, Y., Valia, D., Ingelbeen, B., Campbell, L., Kouanda, J. S., Welgo, A., Diagne, P. M., Riems, B., Hardy, L., Wouters, E., Meudec, M., van der Sande, M. A. B., Halidou, T., Cooper, B. S., van Kleef, E., & CABU-EICO study team (2026). Effects of a community-based intervention bundle on household transmission of extended spectrum β-lactamase-producing Escherichia coli in rural Burkina Faso to target community-level drivers of antimicrobial resistance in sub-Saharan Africa: a cluster-randomised trial. The Lancet Microbe. https://doi.org/10.1016/j.lanmic.2026.101427
Vancouver
Aizouk R, Sibidou Y, Valia D, Ingelbeen B, Campbell L, Kouanda JS, et al. Effects of a community-based intervention bundle on household transmission of extended spectrum β-lactamase-producing Escherichia coli in rural Burkina Faso to target community-level drivers of antimicrobial resistance in sub-Saharan Africa: a cluster-randomised trial. The Lancet Microbe. 2026. doi:10.1016/j.lanmic.2026.101427
BibTeX
@article{Aizouk2026,
author = {Aizouk, Raneem and Sibidou, Yougbaré and Valia, Daniel and Ingelbeen, Brecht and Campbell, Linda and Kouanda, Juste Stéphane and Welgo, Aminata and Diagne, Papa Mamadou and Riems, Bram and Hardy, Liselotte and Wouters, Edwin and Meudec, Marie and van der Sande, Marianne A B and Halidou, Tinto and Cooper, Ben S and van Kleef, Esther and CABU-EICO study team, CABU-EICO study team},
title = {Effects of a community-based intervention bundle on household transmission of extended spectrum β-lactamase-producing Escherichia coli in rural Burkina Faso to target community-level drivers of antimicrobial resistance in sub-Saharan Africa: a cluster-randomised trial},
journal = {The Lancet Microbe},
year = {2026},
doi = {10.1016/j.lanmic.2026.101427}
}
EUVIMED